These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 29045037

  • 1. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
    Colliard S, Jourde-Chiche N, Clavarino G, Sarrot-Reynauld F, Gout E, Deroux A, Fougere M, Bardin N, Bouillet L, Cesbron JY, Thielens NM, Dumestre-Pérard C.
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
    [Abstract] [Full Text] [Related]

  • 2. Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus.
    Plawecki M, Lheritier E, Clavarino G, Jourde-Chiche N, Ouili S, Paul S, Gout E, Sarrot-Reynauld F, Bardin N, Boëlle PY, Chiche L, Bouillet L, Thielens NM, Cesbron JY, Dumestre-Pérard C.
    PLoS One; 2016 Aug; 11(9):e0160879. PubMed ID: 27631981
    [Abstract] [Full Text] [Related]

  • 3. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H, Ekblom-Kullberg S, Miettinen A.
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [Abstract] [Full Text] [Related]

  • 4. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
    Emad G, Al-Barshomy SM.
    Saudi J Kidney Dis Transpl; 2020 Aug; 31(2):342-352. PubMed ID: 32394906
    [Abstract] [Full Text] [Related]

  • 5. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD, Patwardhan MM, Ghosh K.
    Indian J Dermatol Venereol Leprol; 2010 Jun; 76(2):145-9. PubMed ID: 20228543
    [Abstract] [Full Text] [Related]

  • 8. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K.
    Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
    [Abstract] [Full Text] [Related]

  • 9. Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis.
    Soliman AF, Egailla SE, Abdel-Gawad ER, Mansour AI, ElKhouly TH, Mahgoub MY.
    Egypt J Immunol; 2016 Jan; 23(1):107-116. PubMed ID: 28502158
    [Abstract] [Full Text] [Related]

  • 10. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
    Bourse Chalvon N, Orquevaux P, Giusti D, Gatouillat G, Tabary T, Tonye Libyh M, Chrusciel J, Drame M, Stockton-Bliard G, Amoura Z, Arnaud L, Lorenz HM, Blaison G, Bonnotte B, Magy-Bertrand N, Revuz S, Voll RE, Hinschberger O, Schwarting A, Pham BN, Martin T, Pennaforte JL, Servettaz A.
    Front Immunol; 2020 Jan; 11():597863. PubMed ID: 33381119
    [Abstract] [Full Text] [Related]

  • 11. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus.
    Haddon DJ, Diep VK, Price JV, Limb C, Utz PJ, Balboni I.
    Arthritis Res Ther; 2015 Jun 17; 17(1):162. PubMed ID: 26081107
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 17; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.
    Arthritis Rheum; 2011 Aug 17; 63(8):2436-44. PubMed ID: 21506094
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X, Ren L, Sun G, Yu T, Yao Y, Wang L, Liu F, Zhang L, He X, Liu M.
    Immun Inflamm Dis; 2021 Jun 17; 9(2):407-418. PubMed ID: 33470559
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.